{
    "2019-08-27": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Lilly's LLY Taltz Gets FDA Nod for Ankylosing Spondylitis",
                "features": {
                    "keywords": [
                        "Taltz",
                        "FDA",
                        "Ankylosing Spondylitis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Amgen to Buy Celgene's Otezla: 5 ETF Drugs",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Celgene",
                        "Otezla",
                        "ETF"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Has Novartis NVS Outpaced Other Medical Stocks This Year?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "medical stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}